This is a Validated Antibody Database (VAD) review about human MAP1LC3C, based on 2 published articles (read how Labome selects the articles), using MAP1LC3C antibody in all methods. It is aimed to help Labome visitors find the most suited MAP1LC3C antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MAP1LC3C synonym: ATG8J; LC3C; microtubule-associated proteins 1A/1B light chain 3C; LC3-like protein 2; MAP1 light chain 3-like protein 2; MAP1 light chain 3-like protein 3; MAP1A/MAP1B LC3 C; MAP1A/MAP1B light chain 3 C; autophagy-related protein LC3 C; autophagy-related ubiquitin-like modifier LC3 C

Abcam
rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig 5a
In order to assess the role of E2 and the estrogen receptor in the regulation of renal cell carcinoma growth, Abcam MAP1LC3C antibody (Abcam, ab168813) was used in immunohistochemistry on human samples (fig 5a). Cancer Genomics Proteomics (2016) ncbi
Proteintech Group
rabbit polyclonal
  • immunocytochemistry; human; 1:200; fig 1c
Proteintech Group MAP1LC3C antibody (Proteintech, 18726-1-AP) was used in immunocytochemistry on human samples at 1:200 (fig 1c). PLoS ONE (2015) ncbi
Articles Reviewed
  1. Chen K, Lin C, Huang C, Chen S, Wu S, Chiang H, et al. Dual Roles of 17-? Estradiol in Estrogen Receptor-dependent Growth Inhibition in Renal Cell Carcinoma. Cancer Genomics Proteomics. 2016;13:219-30 pubmed
  2. Koukourakis M, Kalamida D, Giatromanolaki A, Zois C, Sivridis E, Pouliliou S, et al. Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines. PLoS ONE. 2015;10:e0137675 pubmed publisher